Emerging concepts and therapeutic implications of β-adrenergic receptor subtype signaling
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 108 (3) , 257-268
- https://doi.org/10.1016/j.pharmthera.2005.04.006
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Endogenous β3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Loss of β-adrenoceptor response in myocytes overexpressing the Na+/Ca2+-exchangerJournal of Molecular and Cellular Cardiology, 2004
- Selective versus nonselective β-blockade for heart failure therapy: are there lessons to be learned from the COMET trial?Journal of Cardiac Failure, 2003
- p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against β-Adrenergic Receptor-stimulated ApoptosisPublished by Elsevier ,2000
- Both Gs and Gi Proteins Are Critically Involved in Isoproterenol-induced Cardiomyocyte HypertrophyJournal of Biological Chemistry, 1999
- The Myocardial β-Adrenergic System in Spontaneously Hypertensive Heart Failure (SHHF) RatsHypertension, 1999
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- The functional importance of beta1 and beta2 adrenoceptors in the human heartThe American Journal of Cardiology, 1988
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Evidence that ICI 118, 551 is a potent, highly beta2-selective adrenoceptor antagonist and can be used to characterize beta-adrenoceptor populations in tissuesLife Sciences, 1980